Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04850599 |
|---|---|
| Brief Title: | Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma |
| First Submitted : | April 14, 2021 |
| First Submitted that Met QC Criteria : | April 14, 2021 |
| First Posted : | April 20, 2021 |
| Last Update Submitted that Met QC Criteria : | June 14, 2022 |
| Last Update Posted : | June 16, 2022 |